FEV analysis: TCO cut by up to 33 percent through range extender trucks

11.2.2026 12:27:02 CET | news aktuell GmbH | Press Release

Share

Aachen – FEV has published new analysis results on the economic efficiency of electrified commercial vehicles as part of an internal research program. The evaluation of extensive techno-economic data shows: depending on the driving cycle, through trucks with range extender architecture (REEV/Hybrid BEV) the total cost of ownership (TCO) can be reduced by up to 33 percent compared to conventional diesel trucks – while also significantly reducing CO emissions. Even in the most unfavorable long-haul scenario, the TCO declined by approximately 14 percent.

Depending  on the driving cycle through range extender trucks TCO can be reduced by up to 33 percent. Source: FEV
Depending on the driving cycle through range extender trucks TCO can be reduced by up to 33 percent. Source: FEV

Calculations are based on realistic European usage profiles with overnight charging at industrial electricity prices of around 19 cents per kilowatt hour. In regions with lower electricity costs, the advantage is correspondingly higher.

Cost-effectiveness without megawatt charging infrastructure
A key lever of the REEV architecture is the reduced battery size compared to purely battery-electric long-haul trucks. While typical BEV trucks require battery capacities of around 560 kWh, a REEV truck can manage with around 280 kWh. Even with slower AC charging at 22 kW, around 240 kWh can be recharged overnight – enough to power the vehicle almost entirely electrically for the next day. Thus, a megawatt charging infrastructure is not necessary for economical operation.

Significant TCO advantage in the cost-critical commercial vehicle market
The economic advantage of the range extender architecture results from several factors. The smaller battery of a REEV truck reduces vehicle costs and weight while increasing payload. Also, the high proportion of electric driving enables low energy costs, especially when charging at depots at night at industrial electricity prices.

Due to their low dependence on public high-performance charging infrastructure, REEV trucks can be seamlessly integrated into existing depot structures.

Download the press release: https://fev.group/34f5b8

Contacts

Media contact: Marius Strasdat, T +49 241 5689-6452, strasdat@fev.com

Images

Depending  on the driving cycle through range extender trucks TCO can be reduced by up to 33 percent. Source: FEV
Depending on the driving cycle through range extender trucks TCO can be reduced by up to 33 percent. Source: FEV
Download

Subscribe to releases from news aktuell GmbH

Subscribe to all the latest releases from news aktuell GmbH by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from news aktuell GmbH

Grünenthal licenses exclusive South Korean rights to Qutenza® to BCWorld Pharm5.3.2026 08:40:44 CET | Press Release

Aachen, Germany & Yeoju, South Korea, 5 March 2026 – Grünenthal, a global leader in pain management and related diseases, and BCWorld Pharm Co., Ltd. ("BCWP"), a specialty company actively expanding and diversifying its pain management portfolio through global open innovation partnerships, announced today that they have entered into a definitive agreement whereby BCWP will have the exclusive South Korean rights to Qutenza®, a topical, non-systemic, non-opioid patch treatment. In Europe, the product is indicated for the management of peripheral neuropathic pain. Under the agreement, BCWP will be responsible for obtaining marketing authorisation for Qutenza® in South Korea. Upon approval, the company will market and distribute the product. Grünenthal will receive an upfront payment in addition to regulatory and sales-related milestone payments. “We are executing on a dedicated strategy to bring Qutenza® into the Asia-Pacific region to facilitate greater access to non-opioid treatment opt

Grünenthal takes full ownership of Grünenthal Meds, the joint venture established with Kyowa Kirin for its established medicines brands2.3.2026 10:07:51 CET | Press Release

Grünenthal acquired Kyowa Kirin International’s 49% stake in ‘Grünenthal Meds’, a joint venture formed in 2023 to market the established medicines portfolio from Kyowa Kirin International. Through this acquisition, Grünenthal assumes the sole responsibility of a portfolio comprising 12 brands across six therapeutic areas and >60 markets.

Valle Venia presents new song by LPS feat. Lara: Where will it take me27.2.2026 10:15:00 CET | Press Release

The song describes the challenge of trusting the flow, relying on oneself, following one's own values with confidence. In a time when everything seems to begin to dissolve, when disorientation prevails more than ever and when one is searching for something to hold on to, certainty can be found in uncertainty. Lara's authentic interpretation, with her multi-faceted voice, conveys confidence in finding a way for oneself and others. In the faceless, noisy crowd, where glances are not returned and touches are not felt, one is pulled away by an invisible hand. You are on your own, but somewhere there is a light and a hope that guides you when the fog lifts and you find yourself in the certainty of meeting someone who “can read my mind and my soul.” Invisibly connected, across time and space, this path is open.

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye